Feline hyperthyroidism: advances towards novel molecular therapeutics.
Feline hyperthyroidism is the most common endocrine disorder of the elderly cat. Traditionally, the disease is treated by surgical thyroidectomy, medical management with antithyroid drugs or radiation therapy using iodine-131. However, none of these treatments is ideal and molecular therapeutics may offer novel methods of treating the disease. This article reviews the background of, and preliminary investigations into, the development of a transcriptionally targeted somatic gene therapy strategy for the treatment of this feline condition.
Blackwood
L
L
Molecular Therapeutics Research Group, Division of Small Animal Clinical Studies, Faculty of Veterinary Medicine, University of Glasgow.
Argyle
D J
DJ
D000818:Animals; D002371:Cat Diseases / Q000628:therapy*; D002415:Cats; D015316:Genetic Therapy / Q000662:veterinary*; D006980:Hyperthyroidism / Q000188:drug therapy / Q000662:veterinary*; D014162:Transfection / Q000662:veterinary*